426 related articles for article (PubMed ID: 26160304)
1. Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver.
Yamada Y; Nakamura K; Abe J; Hyodo M; Haga S; Ozaki M; Harashima H
J Control Release; 2015 Sep; 213():86-95. PubMed ID: 26160304
[TBL] [Abstract][Full Text] [Related]
2. Packaging of the Coenzyme Q
Yamada Y; Burger L; Kawamura E; Harashima H
Biol Pharm Bull; 2017; 40(12):2183-2190. PubMed ID: 29199241
[TBL] [Abstract][Full Text] [Related]
3. The Use of a Microfluidic Device to Encapsulate a Poorly Water-Soluble Drug CoQ
Hibino M; Yamada Y; Fujishita N; Sato Y; Maeki M; Tokeshi M; Harashima H
J Pharm Sci; 2019 Aug; 108(8):2668-2676. PubMed ID: 30959057
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial delivery of bongkrekic acid using a MITO-Porter prevents the induction of apoptosis in human HeLa cells.
Yamada Y; Nakamura K; Furukawa R; Kawamura E; Moriwaki T; Matsumoto K; Okuda K; Shindo M; Harashima H
J Pharm Sci; 2013 Mar; 102(3):1008-15. PubMed ID: 23315986
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 protect against ischemia/reperfusion induced biochemical and functional changes in rabbit urinary bladder.
Juan YS; Hydery T; Mannikarottu A; Kogan B; Schuler C; Leggett RE; Lin WY; Huang CH; Levin RM
Mol Cell Biochem; 2008 Apr; 311(1-2):73-80. PubMed ID: 18165912
[TBL] [Abstract][Full Text] [Related]
6. Activation of Mitochondrial Oxygen Consumption Rate by Delivering Coenzyme Q
Sato I; Hibino M; Takeda A; Harashima H; Yamada Y
J Pharm Sci; 2024 Jul; 113(7):1836-1843. PubMed ID: 38325738
[TBL] [Abstract][Full Text] [Related]
7. [Development of the MITO-porter, a nano device for mitochondrial drug delivery via membrane fusion].
Yamada Y
Yakugaku Zasshi; 2014; 134(11):1143-55. PubMed ID: 25366911
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Delivery of an Anticancer Drug Via Systemic Administration Using a Mitochondrial Delivery System That Inhibits the Growth of Drug-Resistant Cancer Engrafted on Mice.
Yamada Y; Munechika R; Satrialdi ; Kubota F; Sato Y; Sakurai Y; Harashima H
J Pharm Sci; 2020 Aug; 109(8):2493-2500. PubMed ID: 32376272
[TBL] [Abstract][Full Text] [Related]
9. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes.
Yasuzaki Y; Yamada Y; Harashima H
Biochem Biophys Res Commun; 2010 Jun; 397(2):181-6. PubMed ID: 20580633
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity.
Yamada Y; Munechika R; Kawamura E; Sakurai Y; Sato Y; Harashima H
J Pharm Sci; 2017 Sep; 106(9):2428-2437. PubMed ID: 28478130
[TBL] [Abstract][Full Text] [Related]
12. Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion.
Crestanello JA; Doliba NM; Doliba NM; Babsky AM; Niborii K; Osbakken MD; Whitman GJ
J Surg Res; 2002 Feb; 102(2):221-8. PubMed ID: 11796022
[TBL] [Abstract][Full Text] [Related]
13. A system that delivers an antioxidant to mitochondria for the treatment of drug-induced liver injury.
Hibino M; Maeki M; Tokeshi M; Ishitsuka Y; Harashima H; Yamada Y
Sci Rep; 2023 May; 13(1):6961. PubMed ID: 37164988
[TBL] [Abstract][Full Text] [Related]
14. Melatonin pretreatment enhances the therapeutic effects of exogenous mitochondria against hepatic ischemia-reperfusion injury in rats through suppression of mitochondrial permeability transition.
Chen HH; Chen YT; Yang CC; Chen KH; Sung PH; Chiang HJ; Chen CH; Chua S; Chung SY; Chen YL; Huang TH; Kao GS; Chen SY; Lee MS; Yip HK
J Pineal Res; 2016 Aug; 61(1):52-68. PubMed ID: 26993080
[TBL] [Abstract][Full Text] [Related]
15. Targeting the mitochondrial genome via a dual function MITO-Porter: evaluation of mtDNA levels and mitochondrial function.
Yamada Y; Harashima H
Methods Mol Biol; 2015; 1265():123-33. PubMed ID: 25634272
[TBL] [Abstract][Full Text] [Related]
16. MITO-Porter for Mitochondrial Delivery and Mitochondrial Functional Analysis.
Yamada Y; Harashima H
Handb Exp Pharmacol; 2017; 240():457-472. PubMed ID: 27830347
[TBL] [Abstract][Full Text] [Related]
17. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.
Yamada Y; Furukawa R; Yasuzaki Y; Harashima H
Mol Ther; 2011 Aug; 19(8):1449-56. PubMed ID: 21694702
[TBL] [Abstract][Full Text] [Related]
18. [Targeting mitochondria: innovation from mitochondrial drug delivery system (DDS) to mitochondrial medicine].
Yamada Y; Harashima H
Yakugaku Zasshi; 2012; 132(10):1111-8. PubMed ID: 23037696
[TBL] [Abstract][Full Text] [Related]
19. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.
Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM
Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of coenzyme Q10 nanoparticles on dichlorvos-induced hepatotoxicity and mitochondrial/lysosomal injury.
Eftekhari A; Ahmadian E; Azami A; Johari-Ahar M; Eghbal MA
Environ Toxicol; 2018 Feb; 33(2):167-177. PubMed ID: 29143438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
